Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Remimazolam on MEP in Spine Surgery
NCT05453955Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Aug 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam in Spinal disease (2 arms), sponsored by Korea University Guro Hospital. Primary endpoints: Motor evoked potential (MEP), before cross-over and Motor evoked potential (MEP), after cross-over. Started Aug 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
Spinal disease
Beyond the preview
Go deeper on NCT05453955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05453955.